Introduction
Gastric neuroendocrine tumors (GNETs) are classified into 3 distinct subgroups: type I to III. 1 Type I GNETs arise in patients with chronic atrophic gastritis including autoimmune gastritis. The treatment strategy for GNETs is decided by the presence of associated conditions (Rindi classification) , the number and size of the tumors, the depth of invasion, the distribution of proliferation markers (Ki-67 index), and the presence of metastasis. However, optimal management for GNETs, especially small GNETs, has not yet been definitively determined because the clinical outcomes of the different treatment approaches remain unclear. Endoscopic resection is recommended as the treatment for type I GNETs smaller than 10 mm and limited to mucosa or submucosa. 2 However, endoscopic resection might entail risks of perforation or positive vertical margin because neuroendocrine tumors (NETs) arise from neuroendocrine cells present in the deep layers of mucosa and they frequently grow expansively into submucosal layers. Laparoscopic and endoscopic cooperative surgery (LECS) is applied to epithelial neoplasms, which are difficult to treat with endoscopic submucosal dissection (ESD). We herein report a very small subepithelial lesion (SEL) in a deep layer of submucosa associated with type A chronic atrophic gastritis, which was diagnosed as type I GNET by endoscopic ultrasoundguided fine-needle aspiration biopsy (EUS-FNA) using a forward-viewing and curved linear-array echoendoscope (FVCLA-EUS) 3 and was treated by LECS with regional lymph node dissection.
Case Report
An 80-year-old man was referred to our hospital for pancytopenia, including anemia. Esophagogastroduodenoscopy (EGD) showed type A chronic atrophic gastritis and small SEL on the greater curvature of the gastric body ( Figure 1A and B). Endoscopic ultrasonography (miniprobe, 20 MHz) revealed a homogeneous, hypoechoic lesion located mainly within the submucosal layer closer to the muscularis propria. The size of
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KEyWoRDS
Although we considered ESD as a minimally invasive treatment, there was a potential risk of perforation and positive vertical margin. Therefore, we chose to perform a full-thickness, local excision using LECS (Figure 3 ). After inducing general anesthesia, we secured the laparoscopic view. Although we were unable to detect the tumor laparoscopically from the serous membrane side, the gastric tumor was confirmed by EGD. The lesion was marked endoscopically. Laparoscopically, we incised the greater omentum and approached into the omental bursa cavity. We ligated the right gastroepiploic artery and vein and dissected the nearby lymph nodes designated as No 4d in the tumor area. Subsequently, the sections frozen intraoperatively revealed that those lymph nodes were negative for cancer. A full-thickness layer excision was performed along the marking point using a Dual knife and insulation-tip knife 2 (Olympus Corp., Tokyo, Japan). After an en bloc-resected specimen was removed via the abdominal cavity using an "Endobag," we sutured the postexcisional defect in the gastric posterior wall under laparoscopic view. After completing the full-thickness closure, the endoscope was inserted into the stomach to confirm that it passed the suture site easily and that no air leakage had occurred despite insufflation of the stomach. The surgical procedure was uneventful. The total operation time was 182 minutes. Pathologic examination revealed small, nearly homogeneous neoplastic cells with round or oval nuclei and rich cytoplasm ( Figure 4C ). Immunostaining for chromogranin ( Figure 4D ) and synaptophysin ( Figure 4E ) was positive. The mitotic count was <2% ( Figure 4F ). These 
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3 findings led to the final diagnosis of a GNET G1. The tumor had invaded into a deep layer of submucosa ( Figure 4A ), but the horizontal and vertical margins were free of tumor cells. The patient recovered uneventfully and was discharged on postoperative day 14.
Discussion
In this case, no typical endoscopic findings of NETs were observed, such as a hemispherical reddish polyp with or without a central depression. Moreover, we were unable to reach a diagnosis even by a deeper endoscopic biopsy. Endoscopic ultrasound revealed that the lack of mucosal endoscopic features and inconclusive biopsy specimen was due to the tumor residing in a deep layer of the submucosa. In such a case, we considered that, according to SELs, EUS-FNA is an important modality for diagnosis. Akahoshi et al 4 demonstrated that the diagnostic rates for gastrointestinal stromal tumors (GISTs) smaller than 20 mm, 20 to 40 mm, and 40 mm or larger were, respectively, 71%, 86%, and 100%. Although EUS-FNA could be conducted easily in large SELs, it was technically difficult to perform in small SELs. Our earlier study 3 highlighted the diagnostic capability of EUS-FNA using a FVCLA-EUS with a cap for small SELs: although the mean diameter of the SELs was 10.6 mm and the specimen obtainment rate was 87.5%. Among SELs, NETs in particular might have a potential for metastasis even when they are of a small size. Soga et al 5 reported that even NETs limited to the submucosa had a metastasis rate of 7.9% at <10 mm and 21.4% at 10 to 20 mm. Therefore, obtaining the histologic diagnosis before progression using EUS-FNA is important even for a small SEL from which a histologic specimen cannot be obtained using conventional biopsy methods, particularly for suspected NET. The European Neuroendocrine Tumor Society (ENETS) recommends endoscopic treatment for G1 NETs ≤10 mm that do not extend beyond the submucosal layer and which do not demonstrate lymph node metastasis and recommends surgical treatment for tumors ≥20 mm. The treatment strategy for tumors of 10 to 20 mm remains controversial. 2 Endoscopic mucosal resection (EMR) has been recommended for welllocalized, type I GNETs. However, their complete removal by snare polypectomy or conventional EMR is difficult because GNETs frequently invade the submucosa. Therefore, ESD is useful for removing submucosal tumors including type I GNETs. Studies have demonstrated superior complete resection rates of GNETs using ESD compared with those achieved with EMR. 6 However, endoscopic resection might risk perforation or positive margin because NETs arise from neuroendocrine cells residing in a deep layer of mucosa and they frequently grow expansively in submucosal layers. However, LECS has been described by Hiki et al 7 as the treatment for GIST. GISTs grow expansively in the gastric wall and rarely metastasize to regional lymph nodes. Therefore, partial gastrectomy or laparoscopic wedge resection has been used for the surgical treatment of gastric GIST. In other cases, LECS can prevent excessive resection of the gastric wall by combination with an endoscopic procedure. A retrospective multicenter study described that LECS can be a standard treatment for SELs of the stomach. 8 Now, the technique is beginning to be employed for epithelial neoplasm, which is difficult to treat with ESD because of ulcer coexistence or tumor location, among other reasons. Reportedly, ESD for lesions on the greater curvature of the stomach entails increased perforation risk. We performed LECS in this case because the lesion was in a deep layer of submucosa that crossed to the muscularis propria. Moreover, unlike ESD, LECS can dissect the regional lymph node laparoscopically. Goto et al 9 reported a successful Clinical Medicine Insights: Case Reports case of nonexposed endoscopic wall-inversion surgery, a method of LECS, with sentinel node navigation surgery for early gastric cancer with a risk of lymph node metastasis. We applied this technique to GNET because GNETs ≤10 mm and limited to the submucosa have been shown to metastasize with sufficiently high frequency (7.9%). 5 A multicenter study in Japan 10 described 4 of 71 patients with small type I GNET (<10 mm) who were complicated with capillary invasion (lymphatic invasion in 2, venous invasion in 2).
In conclusion, EUS-FNA using a FVCLA-EUS with a cap is useful for the diagnosis of very small SELs. Subsequent LECS with regional lymph node dissection may be regarded as a therapeutic option even for small GNETs.
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